Evolus, Inc. (LON:0K16)
14.58
+0.43 (3.00%)
At close: Jan 31, 2025
Evolus Employees
Evolus had 332 employees as of December 31, 2024. The number of employees increased by 59 or 21.61% compared to the previous year.
Employees
332
Change (1Y)
59
Growth (1Y)
21.61%
Revenue / Employee
640.64K GBP
Profits / Employee
-121.31K GBP
Market Cap
556.56M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,315 |
Evolus News
- 4 weeks ago - Evolus to Participate in The Needham 24th Annual Virtual Healthcare Conference - Business Wire
- 5 weeks ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Evolus, Inc. 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 7 weeks ago - Evolus, Inc. (EOLS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Evolus Inc Reports Q4 2024 Revenue of $79 Million, Surpassing Estimates; EPS Misses at -$0.11 - GuruFocus
- 7 weeks ago - Evolus posts quarterly profit on strong sales of cosmetic injection - Reuters
- 7 weeks ago - Evolus Reports Record Fourth Quarter and Full-Year 2024 Financial Results; Reaffirms 2025 Guidance - Business Wire
- 2 months ago - Evolus to Participate in Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences - Business Wire